Mohamed Mubasher to Aged
This is a "connection" page, showing publications Mohamed Mubasher has written about Aged.
Connection Strength
0.264
-
Henry Akintobi T, Quarells RC, Bednarczyk RA, Khizer S, Taylor BD, Nwagwu MNA, Hill M, Ord??ez CE, Sabben G, Spivey S, Davis K, Best ML, Chen AZ, Lovell K, Craig LS, Mubasher M. Community-Centered Assessment to Inform Pandemic Response in Georgia (US). Int J Environ Res Public Health. 2023 05 08; 20(9).
Score: 0.103
-
Islam SJ, Kim JH, Topel M, Liu C, Ko YA, Mujahid MS, Sims M, Mubasher M, Ejaz K, Morgan-Billingslea J, Jones K, Waller EK, Jones D, Uppal K, Dunbar SB, Pemu P, Vaccarino V, Searles CD, Baltrus P, Lewis TT, Quyyumi AA, Taylor H. Cardiovascular Risk and Resilience Among Black Adults: Rationale and Design of the MECA Study. J Am Heart Assoc. 2020 05 05; 9(9):e015247.
Score: 0.021
-
Kim JH, Lewis TT, Topel ML, Mubasher M, Li C, Vaccarino V, Mujahid MS, Sims M, Quyyumi AA, Taylor HA, Baltrus PT. Identification of Resilient and At-Risk Neighborhoods for Cardiovascular Disease Among Black Residents: the Morehouse-Emory Cardiovascular (MECA) Center for Health Equity Study. Prev Chronic Dis. 2019 05 09; 16:E57.
Score: 0.019
-
Maturi RK, Bleau L, Saunders J, Mubasher M, Stewart MW. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY. Retina. 2015 Aug; 35(8):1604-14.
Score: 0.015
-
AlShardan MM, Mubasher M, Orz Y, AlYamany M. Factors that predict hydrocephalus following intraventricular hemorrhage. Br J Neurosurg. 2015 Apr; 29(2):225-8.
Score: 0.014
-
Al-Dhahri SF, Mubasher M, Mufarji K, Allam OS, Terkawi AS. Factors predicting post-thyroidectomy hypoparathyroidism recovery. World J Surg. 2014 Sep; 38(9):2304-10.
Score: 0.014
-
Al-Dhahri SF, Mubasher M, Al-Muhawas F, Alessa M, Terkawi RS, Terkawi AS. Early prediction of oral calcium and vitamin D requirements in post-thyroidectomy hypocalcaemia. Otolaryngol Head Neck Surg. 2014 Sep; 151(3):407-14.
Score: 0.014
-
Fareed MM, AlAmro AS, Bayoumi Y, Tunio MA, Ismail AS, Akasha R, Mubasher M, Al Asiri M. Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma. BMC Cancer. 2013 Jul 01; 13:318.
Score: 0.013
-
Heijl A, Leske MC, Bengtsson B, Bengtsson B, Hussein M. Measuring visual field progression in the Early Manifest Glaucoma Trial. Acta Ophthalmol Scand. 2003 Jun; 81(3):286-93.
Score: 0.013
-
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003 Jan; 121(1):48-56.
Score: 0.013
-
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002 Oct; 120(10):1268-79.
Score: 0.012
-
Smith MR, Khanuja PS, al-Katib A, Bishop CR, Andersen J, Hussein ME, Karanes C. Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease. Cancer. 1994 Feb 15; 73(4):1264-9.
Score: 0.007
-
Simon MS, Hoff M, Hussein M, Martino S, Walt A. An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology. Breast Cancer Res Treat. 1993 Sep; 27(3):211-9.
Score: 0.003
-
al-Katib A, Mohammad RM, Dan M, Hussein ME, Akhtar A, Pettit GR, Sensenbrenner LL. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro. Exp Hematol. 1993 Jan; 21(1):61-5.
Score: 0.003